Innovation and Technology Tariff
At the start of November 2016, NHS England set out plans to fast-track the introduction of six new types of medical technology products and apps during 2017/18 through the Innovation and Technology Tariff (ITT). The ITT removes the need for multiple local price negotiations and guarantees automatic reimbursement.
For five of the above NHS England will centrally pick up the costs, where these have been incurred in line with requirements about use. The sixth innovation is an alternative to existing surgical procedures, and is already funded as part of tariff calculations.
The innovation categories are:
- Guided mediolateral episiotomy to minimise the risk of obstetric anal sphincter injury
- Arterial connecting systems to reduce bacterial contamination and the accidental administration of medication
- Pneumonia prevention systems which are designed to stop ventilator-associated pneumonia
- Web based applications for the self-management of chronic obstructive pulmonary disease (COPD)
- Frozen Faecal microbiota transplantation (FMT) for recurrent Clostridium difficile infection rates
- Management of Benign prostatic hyperplasia as a day case (purchased through National Tariff).
Separately from the tariff, NHS England is centrally funding the purchase of mobile ECG technology, which will be managed through the AHSN Network.
The ITT went live on 1 April 2017 and NHS England is keen to encourage the adoption and spread of these technologies.
Innovation and Technology Payment
In his speech at Confed17, Simon Stevens, Chief Executive of NHS England, announced the launch of the NHS Innovation and Technology Payment (ITP). This programme builds on the Innovation and Technology Tariff (ITT) that went live on 1 April 2017.
The ITP aims to support the NHS in adopting innovation by removing financial or procurement barriers to uptake of innovative products or technologies. This programme will be delivered in partnership with the AHSNs, sponsors, national and international experts.
Innovations (specifically medical devices, digital platforms and technologies) accepted on to the ITP will inform an innovation or technology theme, which will then be incentivised via financial or procurement support. This will enable the successful applicant’s innovation – along with any others that meet the same criteria – to be incentivised for use in the NHS.
Any payment, tariff or purchase of products will be available to the NHS from April 2018 for a period of one year, at which point the programme and themes will be reviewed.
Applications are now closed.
More information about the scheme can be found on the NHS Innovation Exchange webpage
What is the Innovation and Technology Payment (ITP) and how does it differ from the Innovation and Technology Tariff (ITT)?
Both programmes are designed to remove significant barriers to the spread and adoption of new innovations and the need for multiple price negotiations. The ITP will allow for a much wider range of innovation types and development areas with increased scope for those innovations in the community, primary care and in digital health services.
The ITP builds on the continuing commitment of NHS England to build on the recommendations of the Accelerated Access Review (AAR) by offering routes and support of new innovations and technologies that can make a real difference to patient care and outcomes.
For further information, contact Urszula Kapoulas, Innovation & Adoption Project Manager email@example.com
- NHS England Innovation and Technology Tariff 2017 to 2019 Technical notes
- Innovation Exchange: Innovation and Technology Payment
- Innovation Exchange: Innovation and Technology Payments FAQs
- Slides from launch event: Procuring NIA innovations via the NHS Innovation and Technology Tariff. The role of England’s 15 AHSNs in supporting and spreading innovation